NCT05348343Phase 1/2Completed
Activated PRP for Treatment of Androgenetic Alopecia
A Pilot Clinical 'Proof of Concept' Study of Activated Platelet-rich Plasma (PRP) in Subjects With Androgenetic Alopecia (AGA)
In the register
This trial is not attached to a programme in the register yet. Unattached trials are kept on purpose: they are where new programmes turn up first.
What the registry records
- Status
- Completed
- Declared phase
- Phase 1/2
- Sponsor
- Santiste Medical Inc.
- Participants (registry)
- 17
- Start
- May 2022
- Primary completion
- September 2023
- Study completion
- September 2023
- Last registry update
- April 2025
- Countries
- United States
Conditions studied: Androgenetic Alopecia
Interventions: Autologous platelet-rich plasma
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.